These findings were coherent with what happened after an overexpression of RNF213 R4810K or after a downregulation of securin in HUVECs, suggesting hiPSC-ECs as a promising vascular in vitro model for Moyamoya disease [82]. The gene discussed is RNF213; the disease is Moyamoya disease.